Marco Lobba, Ph.D.
Co-Founder and CEO
Marco Lobba, PhD, co-founded CatenaBio to advance the development of targeted therapeutics at the intersection of chemistry and molecular biology. He is a co-inventor of the company’s CysTyr platform and has authored numerous patents and publications. His expertise in protein conjugation has driven innovations in multi-payload conjugates (MPCs), CRISPR gene editors, and cell-based therapies. Marco earned his PhD from the University of California, Berkeley, where he trained in the labs of Nobel Laureate Jennifer Doudna and Chemistry Department Chair Matthew Francis.